Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells

Journal of Immunology

Volumn 174, Issue 1, 2005, Pages 99-109

  Dikopoulos, Nektarios ^a   Bertoletti, Antonio ^b   Kröger, Andrea ^c   Hauser, Hansjörg ^c   Schirmbeck, Reinhold ^a   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GAMMA INTERFERON; INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 2 RECEPTOR; PROTEIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; T LYMPHOCYTE ACTIVATION;

EID: 10844241527     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.1.99     Document Type: Article

References (65)

1. Müller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918.
2. Van den Broek, M. F., U. Muller, S. Huang, R. M. Zinkernagel, and M. Aguet. 1995. Immune defense in mice lacking type I and/or type II interferon receptors. Immunol. Rev. 148:5.
3. Biron, C. A. 2001. Interferons α and β as immune regulators. Immunity 14:661.
4. Marrack, P., and J. Kappler. 2004. Control of T cell viability. Annu. Rev. Immunol. 22:765.
5. Matikainen, S., T. Sareneva, T. Ronni, A. Lehtonen, P. J. Koskinen, and I. Julkunen. 1999. Interferon-α activates multiple STAT proteins and up-regulates proliferation-associated IL-2Rα, c-myc, and pim-1 genes in human T cells. Blood 93:1980.
6. + T cells after the injection of tumor cells expressing IFN-α1 into syngeneic mice. Cancer Res. 58:5795.
7. Hiroishi, K., T. Tuting, and M. T. Lotze. 2000. IFN-α-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs. J. Immunol. 164:567.
8. + T lymphocytes by immunostimulatory DNA-based vaccines. J. Immunol. 168:4907.
9. Mattei, F., G. Schiavoni, F. Belardelli, and D. F. Tough. 2001. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167:1179.
10. + T cell turnover in vivo by IL-12, IL-18, and IFNγ. J. Immunol. 166:6007.
11. Nguyen, K. B., T. P. Salazar-Mather, M. Y. Dalod, J. B. van Deusen, X. Q. Wei, F. Y. Liew, M. A. Caligiuri, J. E. Durbin, and C. A. Biron. 2002. Coordinated and distinct roles for IFN-αβ, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169:4279.
12. McNally, J. M., C. C. Zarozinski, M. Y. Lin, M. A. Brehm, H. D. Chen, and R. M. Welsh. 2001. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J. Virol. 75:5965.
13. + T cells during reconstitution of lymphopenic environments. J. Immunol. 171:655.
14. Welsh, R. M., L. K. Selin, and E. Szomolanyi-Tsuda. 2004. Immunological memory to viral infections. Annu. Rev. Immunol. 22:711.
15. Kim, S. K., and R. M. Welsh. 2004. Comprehensive early and lasting loss of memory CD8 T cells and functional memory during acute and persistent viral infections. J. Immunol. 172:3139.
16. Dondi, E., L. Rogge, G. Lutfalla, G. Uze, and S. Pellegrini. 2003. Down-modulation of responses to type I IFN upon T cell activation. J. Immunol. 170:749.
17. + T cell function by the IFN-induced and double-stranded RNA-activated kinase PKR. J. Immunol. 165:6896.
18. + dendritic cells to produce type I IFN. J. Immunol. 166:2291.
19. Sareneva, T., I. Julkunen, and S. Matikainen. 2000. IFN-α and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J. Immunol. 165:1933.
20. Freudenberg, M. A., T. Merlin, C. Kalis, Y. Chvatchko, H. Stubig, and C. Galanos. 2002. A murine, IL-12-independent pathway of IFN-γ induction by Gram-negative bacteria based on STAT4 activation by type I IFN and IL-18 signaling. J. Immunol. 169:1665.
21. McRae, B. L., R. T. Semnani, M. P. Hayes, and G. A. van Seventer. 1998. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J. Immunol. 160:4298.
22. Cousens, L. P., R. Peterson, S. Hsu, A. Dorner, J. D. Altman, R. Ahmed, and C. A. Biron. 1999. Two roads diverged: interferon α/β- and interleukin 12-mediated pathways in promoting T cell interferon-γ responses during viral infection. J. Exp. Med. 189:1315.
23. McRae, B. L., B. A. Beilfuss, and G. A. van Seventer. 2000. IFN-β differentially regulates CD40-induced cytokine secretion by human dendritic cells. J. Immunol. 164:23.
24. Manca, C., L. Tsenova, A. Bergtold, S. Freeman, M. Tovey, J. M. Musser, C. E. Barry III, V. H. Freedman, and G. Kaplan. 2001. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFNαβ. Proc. Natl. Acad. Sci. USA 98:5752.
25. Wang, X., M. Chen, K. P. Wandinger, G. Williams, and S. Dhib-Jalbut. 2000. IFN-β1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism: relevance to IFN-β1b therapeutic effects in multiple sclerosis. J. Immunol. 165:548.
26. Huang, Y. M., Y. Hussien, D. Yarilin, B. G. Xiao, Y. J. Liu, and H. Link. 2001. Interferon-β induces the development of type 2 dendritic cells. Cytokine 13:264.
27. Kadowaki, N., S. Antonenko, J. Y. Lau, and Y. J. Liu. 2000. Natural interferon αβ-producing cells link innate and adaptive immunity. J. Exp. Med. 192:219.
28. Mohty, M., A. Vialle-Castellano, J. A. Nunes, D. Isnardon, D. Olive, and B. Gaugler. 2003. IFN-α skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. J. Immunol. 171:3385.
29. Honda, K., T. Mizutani, and T. Taniguchi. 2004. Negative regulation of IFN-α/β signaling by IFN regulatory factor 2 for homeostatic development of dendritic cells. Proc. Natl. Acad. Sci. USA 101:2416.
30. + precursors. Blood 96:210.
31. Luft, T., P. Luetjens, H. Hochrein, T. Toy, K. A. Masterman, M. Rizkalla, C. Maliszewski, K. Shortman, J. Cebon, and E. Maraskovsky. 2002. IFN-α enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. Int. Immunol. 14:367.
32. Pestka, S., C. D. Krause, D. Sarkar, M. R. Walter, Y. Shi, and P. B. Fisher. 2004. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22:929.
33. Payvandi, F., S. Amrute, and B. P. Fitzgerald. 1998. Exogenous and endogenous IL-10 regulate IFN-α production by peripheral blood mononuclear cells in response to viral stimulation. J. Immunol. 160:5861.
34. Ziegler-Heitbrock, L., M. Lotzerich, A. Schaefer, T. Werner, M. Frankenberger, and E. Benkhart. 2003. IFN-α induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3. J. Immunol. 171:285.
35. Durbin, J. E., S. A. Fernandez, C. K. Lee, T. D. Rao, A. B. Frey, T. M. Moran, S. Vukmanovic, S. A. Garcia, and D. E. Levy. 2000. Type I IFN modulates innate and specific antiviral immunity. J. Immunol. 164:4220.
36. Roncarolo, M. G., R. Bacchetta, C. Bordignon, S. Narula, and M. K. Levings. 2001. Type 1 T regulatory cells. Immunol. Rev. 182:68.
37. Wakkach, A., N. Fournier, V. Brun, J. P. Breittmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18:605.
38. Levings, M. K., R. Sangregorio, F. Galbiati, S. Squadrone, M. R. de Waal, and M. G. Roncarolo. 2001. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166:5530.
39. Vasconcellos, R., D. Braun, A. Coutinho, and J. Demengeot. 1999. Type I IFN sets the stringency of B cell repertoire selection in the bone marrow. Int. Immunol. 11:279.
40. Teige, I., A. Treschow, A. Teige, R. Mattsson, V. Navikas, T. Leanderson, R. Holmdahl, and S. Issazadeh-Navikas, 2003. IFNβ gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 170:4776.
41. Böhm, W., A. Kuhröber, T. Paier, T. Mertens, J. Reimann, and R. Schirmbeck. 1996. DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection. J. Immunol. Methods 193:29.
42. b-restricted epitopes in natural variants of the hepatitis B surface antigen. Eur. J. Immunol. 33:2429.
43. + T cells. J. Immunol. 171:5198.
44. + regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 168:5979.
45. + T cells are found in the liver post-vaccination. J. Hepatol. 39:910.
46. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057.
47. + T cell-induced transfer colitis. Eur. J. Immunol. 34:705.
48. + T cell immunity in the liver. Hepatology 40:300.
49. Sun, S., X. Zhang, D. F. Tough, and J. Sprent. 1998. Type I interferon-mediated stimulation of T cells by CpG DNA. J. Exp. Med. 188:2335.
50. Van Uden, J. H., C. H. Tran, D. A. Carson, and E. Raz. 2001. Type I interferon is required to mount an adaptive response to immunostimulatory DNA. Eur. J. Immunol. 31:3281.
51. + T cell responses. J. Exp. Med. 196:1585.
52. + T cells. Proc. Natl. Acad. Sci. USA 99:8832.
53. + T cell activation. Eur. J. Immunol. 33:3473.
54. + T cell responses. J. Exp. Med. 198:889.
55. + T cells by regulatory T cells during persistent retroviral infection. Immunity 20:293.
56. + regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease. J. Exp. Med. 199:25.
57. Malmgaard, L., T. P. Salazar-Mather, C. A. Lewis, and C. A. Biron. 2002. Promotion of αβ interferon induction during in vivo viral infection through αβ interferon receptor/STAT1 system-dependent and -independent pathways. J. Virol. 76:4520.
58. Takayanagi, H., S. Kim, K. Matsuo, H. Suzuki, T. Suzuki, K. Sato, T. Yokochi, H. Oda, K. Nakamura, N. Ida, et al. 2002. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature 416:744.
59. Deonarain, R., A. Verma, A. C. Porter, D. R. Gewert, L. C. Platanias, and E. N. Fish. 2003. Critical roles for IFN-β in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor-α. Proc. Natl. Acad. Sci. USA 100:13453.
60. Barnes, E., G. Harcourt, D. Brown, M. Lucas, R. Phillips, G. Dusheiko, and P. Klenerman. 2002. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 36:743.
61. Cramp, M. E., S. Rossol, S. Chokshi, P. Carucci, R. Williams, and N. V. Naoumov. 2000. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 118:346.
62. Boni, C., A. Bertoletti, A. Penna, A. Cavalli, M. Pilli, S. Urbani, P. Scognamiglio, R. Boehme, R. Panebianco, F. Fiaccadori, and C. Ferrari. 1998. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J. Clin. Invest. 102:968.
63. Boni, C., A. Penna, G. S. Ogg, A. Bertoletti, M. Pilli, C. Cavallo, A. Cavalli, S. Urbani, R. Boehme, R. Panebianco, et al. 2001. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 33:963.
64. Marinos, G., N. V. Naoumov, and R. Williams. 1996. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection. Hepatology 24:991.
65. Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3:253.